Search research articles
Contact Us
Filters
Showing results (91-100 of 106) with videos related to
Page
of 11
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
M Ducreux, P Rougier, J-P Pignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2012
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial
A Patrikidou, S Chabaud, I Ray-Coquard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 16, 2025
Histoplasma antigenuria prevalence in patients with advanced HIV disease in Côte d'Ivoire: a prospective trial ancillary study
Aude Sturny-Leclère, Ugo Françoise, Anani D Badjé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival
T Conroy, P L Etienne, A Adenis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group
T Conroy, P L Etienne, A Adenis, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
November 25, 2004
[Clinical practice guidelines: 2004 Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach--radiotherapy]
M Ychou, G Gory-Delabaere, P Blanc, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 10, 2018
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours
H-T Arkenau, A Italiano, G Mak, et al.
British Journal of Cancer
|
January 11, 2014
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial
E Samalin, O Bouché, S Thézenas, et al.
Journal of Fungi (Basel, Switzerland)
|
March 6, 2021
Summary of Guidelines for Managing Histoplasmosis among People Living with HIV
Freddy Perez, Diego H Caceres, Nathan Ford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2014
Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial
A Adenis, J-Y Blay, B Bui-Nguyen, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 106) with videos related to
Sort By:
Page
of 11
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
A randomised trial comparing 5-FU with 5-FU plus cisplatin in advanced pancreatic carcinoma
M Ducreux, P Rougier, J-P Pignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 24, 2012
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial
A Patrikidou, S Chabaud, I Ray-Coquard, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 16, 2025
Histoplasma antigenuria prevalence in patients with advanced HIV disease in Côte d'Ivoire: a prospective trial ancillary study
Aude Sturny-Leclère, Ugo Françoise, Anani D Badjé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 22, 2002
Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival
T Conroy, P L Etienne, A Adenis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1996
Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group
T Conroy, P L Etienne, A Adenis, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|
November 25, 2004
[Clinical practice guidelines: 2004 Standards, Options and Recommendations for the management of patient with adenocarcinoma of the stomach--radiotherapy]
M Ychou, G Gory-Delabaere, P Blanc, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 10, 2018
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours
H-T Arkenau, A Italiano, G Mak, et al.
British Journal of Cancer
|
January 11, 2014
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial
E Samalin, O Bouché, S Thézenas, et al.
Journal of Fungi (Basel, Switzerland)
|
March 6, 2021
Summary of Guidelines for Managing Histoplasmosis among People Living with HIV
Freddy Perez, Diego H Caceres, Nathan Ford, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 15, 2014
Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial
A Adenis, J-Y Blay, B Bui-Nguyen, et al.
Page
of 11